LifeVantage (LFVN) Stock Price

LifeVantage Price

NASDAQ·CLOSED
6.69USD+0.15 (+2.27 %)
Market closed

Revenue has compounded at 20.0% per year over the past 19 years to 228.53 M USD. Earnings per share have grown at 0.9% per year over the last 13 years. LifeVantage's net margin stands at 4.3%, down from 5.9% several years earlier. LifeVantage currently offers a dividend yield of about 2.62%. The payout ratio is around 23% of earnings. The dividend has grown at 24.8% per year over the past 3 years. Analysts set a median price target of 14.79 USD, implying 121.1% above the current price. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus. Over the past year LifeVantage shares have lost 48.9%. The stock trades about 66% above its 52-week low.

LifeVantage stock price

Volume
Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of LifeVantage over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how LifeVantage stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing LifeVantage's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

LifeVantage Stock Price History
DateLifeVantage Price
8/5/20266.69 USD
8/4/20266.54 USD
8/3/20266.58 USD
7/31/20266.43 USD
7/30/20266.29 USD
7/29/20266.33 USD
7/27/20266.26 USD
7/23/20266.27 USD
7/22/20266.35 USD
7/21/20266.40 USD
7/20/20266.26 USD
7/17/20266.20 USD
7/16/20266.18 USD
7/15/20266.20 USD
7/14/20266.20 USD
7/13/20266.16 USD
7/10/20266.24 USD
7/9/20266.25 USD
7/8/20266.18 USD
7/7/20266.24 USD
7/6/20266.18 USD
7/2/20266.22 USD
7/1/20266.25 USD
6/30/20266.24 USD
6/29/20266.20 USD
6/26/20266.62 USD
6/25/20266.65 USD
6/24/20266.23 USD
6/23/20266.18 USD
6/22/20265.95 USD
6/18/20266.41 USD
6/17/20266.06 USD
6/16/20266.04 USD
6/15/20266.61 USD
6/12/20269.05 USD
6/11/20269.49 USD
6/10/20269.48 USD
6/9/20269.50 USD
6/8/202610.70 USD
6/5/20269.97 USD
6/4/20269.31 USD
6/3/20268.32 USD
6/2/20268.62 USD
6/1/20269.43 USD
5/29/20267.87 USD
5/28/20267.67 USD
5/27/20268.05 USD
5/26/20266.93 USD
5/22/20265.61 USD
5/21/20265.37 USD
5/20/20265.25 USD
5/19/20265.26 USD
5/18/20265.19 USD
5/15/20265.17 USD
5/14/20265.12 USD
5/13/20265.27 USD
5/12/20265.15 USD
5/11/20265.14 USD
5/8/20265.34 USD
5/7/20265.02 USD
5/6/20266.00 USD
5/5/20265.49 USD
5/4/20265.13 USD
5/1/20265.43 USD
4/30/20265.05 USD
4/29/20265.05 USD
4/28/20265.19 USD
4/27/20265.51 USD
4/24/20265.08 USD
4/23/20264.80 USD
4/22/20264.90 USD
4/21/20264.91 USD
4/20/20265.13 USD
4/17/20264.78 USD
4/16/20264.57 USD
4/15/20264.35 USD
4/14/20264.14 USD
4/13/20264.17 USD
4/10/20264.15 USD
4/9/20264.02 USD
4/8/20264.07 USD
4/7/20264.04 USD
4/6/20264.18 USD
4/2/20264.25 USD
4/1/20264.20 USD
3/31/20264.32 USD
3/30/20264.40 USD
3/27/20264.30 USD
3/26/20264.29 USD
3/25/20264.29 USD
3/24/20264.33 USD
3/23/20264.54 USD
3/20/20264.67 USD
3/19/20264.73 USD
3/18/20264.65 USD
3/17/20264.77 USD
3/16/20265.15 USD
3/13/20265.19 USD
3/12/20265.15 USD
3/11/20265.28 USD
3/10/20265.20 USD
3/9/20265.09 USD
3/6/20264.88 USD
3/5/20264.70 USD
3/4/20264.91 USD
3/3/20264.80 USD
3/2/20264.52 USD
2/27/20264.65 USD
2/26/20264.68 USD
2/25/20264.67 USD
2/24/20264.53 USD
2/23/20264.59 USD
2/20/20264.85 USD
2/19/20265.06 USD
2/18/20264.93 USD
2/17/20264.94 USD
2/13/20265.03 USD
2/12/20264.92 USD
2/11/20265.09 USD
2/10/20264.93 USD
2/9/20265.07 USD
2/6/20265.03 USD
2/5/20264.62 USD
2/4/20265.55 USD
2/3/20265.36 USD
2/2/20265.51 USD
1/30/20265.30 USD
1/29/20265.46 USD
1/28/20265.79 USD
1/27/20265.95 USD
1/26/20265.86 USD
1/23/20266.14 USD
1/22/20265.97 USD
1/21/20265.70 USD
1/20/20266.01 USD
1/16/20266.34 USD
1/15/20266.33 USD
1/14/20266.10 USD
1/13/20266.20 USD
1/12/20266.79 USD
1/9/20266.49 USD
1/8/20266.34 USD
1/7/20266.24 USD
1/6/20266.21 USD
1/5/20266.09 USD
1/2/20266.03 USD
12/31/20256.16 USD
12/30/20256.05 USD
12/29/20256.25 USD
12/26/20256.07 USD
12/24/20256.33 USD
12/23/20256.23 USD
12/22/20255.99 USD
12/19/20256.20 USD
12/18/20256.26 USD
12/17/20256.37 USD
12/16/20256.33 USD
12/15/20256.45 USD
12/12/20256.50 USD
12/11/20256.52 USD
12/10/20256.65 USD
12/9/20256.57 USD
12/8/20256.61 USD
12/5/20256.60 USD
12/4/20256.97 USD
12/3/20256.86 USD
12/2/20256.48 USD
12/1/20256.63 USD
11/28/20256.87 USD
11/26/20256.76 USD
11/25/20256.77 USD
11/24/20256.54 USD
11/21/20256.43 USD
11/20/20256.31 USD
11/19/20256.40 USD
11/18/20256.48 USD
11/17/20256.29 USD
11/14/20256.62 USD
11/13/20256.47 USD
11/12/20256.64 USD
11/11/20256.58 USD
11/10/20257.26 USD
11/7/20257.40 USD
11/6/20256.75 USD
11/5/20257.31 USD
11/4/20257.00 USD
11/3/20257.34 USD
10/31/20258.19 USD
10/30/20258.07 USD
10/29/20258.15 USD
10/28/20258.51 USD
10/27/20258.53 USD
10/24/20258.67 USD
10/23/20258.82 USD
10/22/20258.67 USD
10/21/20258.63 USD
10/20/20258.54 USD
10/17/20258.81 USD
10/16/20258.97 USD
10/15/20259.04 USD
10/14/20259.04 USD
10/13/20259.06 USD
10/10/20258.96 USD
10/9/20259.38 USD
10/8/20259.20 USD
10/7/20259.25 USD
10/6/20259.51 USD
10/3/20259.48 USD
10/2/20259.57 USD
10/1/20259.56 USD
9/30/20259.73 USD
9/29/20259.76 USD
9/26/202510.19 USD
9/25/20259.99 USD
9/24/202510.28 USD
9/23/202510.57 USD
9/22/202510.55 USD
9/19/202510.63 USD
9/18/202510.90 USD
9/17/202510.75 USD
9/16/202510.71 USD
9/15/202510.68 USD
9/12/202511.13 USD
9/11/202511.72 USD
9/10/202511.23 USD
9/9/202511.84 USD
9/8/202511.44 USD
9/5/202512.11 USD
9/4/202513.46 USD
9/3/202513.57 USD
9/2/202513.55 USD
8/29/202513.10 USD
8/28/202513.10 USD
8/27/202513.41 USD
8/26/202512.93 USD
8/25/202512.89 USD
8/22/202513.08 USD
8/21/202512.57 USD
8/20/202512.40 USD
8/19/202513.09 USD
8/18/202513.69 USD
8/15/202513.49 USD
8/14/202513.68 USD
8/13/202514.51 USD
8/12/202514.16 USD
8/11/202513.76 USD
8/8/202513.30 USD
8/7/202513.09 USD
Access this data via the Eulerpool API

LifeVantage Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
206.36 M USD
7.58 M USD
3.12 M USD
Jan 1, 2023
213.40 M USD
4.26 M USD
2.54 M USD
Jan 1, 2024
200.16 M USD
4.33 M USD
2.94 M USD
Jan 1, 2025
228.53 M USD
12.20 M USD
9.81 M USD
Jan 1, 2026 (e)
184.20 M USD
7.19 M USD
7.45 M USD
Jan 1, 2027 (e)
178.37 M USD
6.96 M USD
5.93 M USD
Jan 1, 2028 (e)
165.30 M USD
6.45 M USD
5.32 M USD
Jan 1, 2029 (e)
291.60 M USD
11.38 M USD
20.13 M USD

LifeVantage Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 7, 2026, 8:14 PM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
DIV.USD
DIV. GROWTH%
SHARESM
2014201520162017201820192020202120222023202420252026e2027e2028e2029e
213.00190.00206.00199.00203.00225.00232.00220.00206.00213.00200.00228.00184.00178.00165.00291.00
2.40-10.808.42-3.402.0110.843.11-5.17-6.363.40-6.1014.00-19.30-3.26-7.3076.36
84.5185.2683.5083.4282.7683.1183.6282.2781.5579.8179.0080.2680.2680.2680.2680.26
180.00162.00172.00166.00168.00187.00194.00181.00168.00170.00158.00183.00147.68142.87132.43233.57
19.0013.0012.004.0010.009.0015.0017.007.004.004.0012.007.006.006.0011.00
8.926.845.832.014.934.006.477.733.401.882.005.263.803.373.643.78
11.006.006.001.005.007.0011.0012.003.002.002.009.007.005.005.0020.00
57.14-45.45-83.33400.0040.0057.149.09-75.00-33.33350.00-22.22-28.57300.00
0.120.140.160.180.190.210.24
16.6714.296.255.8816.6714.29
14.3914.0214.1314.1514.9614.5614.4413.2912.5412.6113.1812.7512.7512.7512.7512.75
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales LifeVantage generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue LifeVantage retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare LifeVantage's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares LifeVantage has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against LifeVantage's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

LifeVantage stock margins

The LifeVantage margin analysis displays the gross margin, EBIT margin, as well as the profit margin of LifeVantage. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for LifeVantage.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
82.66 %
8.00 %
5.86 %
Jan 1, 2022
81.54 %
3.67 %
1.51 %
Jan 1, 2023
79.67 %
2.00 %
1.19 %
Jan 1, 2024
79.30 %
2.16 %
1.47 %
Jan 1, 2025
80.37 %
5.34 %
4.29 %
Jan 1, 2026 (e)
80.37 %
3.90 %
4.04 %
Jan 1, 2027 (e)
80.37 %
3.90 %
3.32 %
Jan 1, 2028 (e)
80.37 %
3.90 %
3.22 %

LifeVantage Stock Revenue, EBIT, Earnings per Share

The LifeVantage earnings per share therefore indicates how much revenue LifeVantage has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
16.57 USD
1.33 USD
0.97 USD
Jan 1, 2022
16.45 USD
0.60 USD
0.25 USD
Jan 1, 2023
16.92 USD
0.34 USD
0.20 USD
Jan 1, 2024
15.19 USD
0.33 USD
0.22 USD
Jan 1, 2025
17.93 USD
0.96 USD
0.77 USD
Jan 1, 2026 (e)
14.18 USD
0.56 USD
0.57 USD
Jan 1, 2027 (e)
13.73 USD
0.55 USD
0.46 USD
Jan 1, 2028 (e)
12.73 USD
0.51 USD
0.41 USD

LifeVantage business model & stock analysis

LifeVantage Corp is a US-based company that was founded in 2003. It specializes in biohacking products and offers a wide range of products for improving health and well-being. The company is known for its use of innovative technologies in product manufacturing, ensuring that each product is of the highest quality. LifeVantage is headquartered in Salt Lake City, Utah, and has branch offices in the US, Mexico, Hong Kong, Thailand, Japan, and Australia. Its mission is to help people improve their quality of life and optimize their health. The company offers an extensive range of products under the motto of "biohacking." Some of the key products offered by LifeVantage are nutritional supplements that utilize nutrients, antioxidants, and plant extracts to strengthen the immune system and support the body's detoxification process. The company's products are categorized into various categories, ranging from skincare products to nutritional supplements. One of LifeVantage's most well-known products is Protandim, a nutritional supplement that contains eight essential nutrients and antioxidants, which help reduce inflammation in the body. Protandim has been developed by LifeVantage and has proven to be an effective remedy against inflammation and oxidative damage in the body. The company also offers other products, such as TrueScience Anti-Aging Cream, which is based on the use of nutrients and antioxidants for skin rejuvenation. This innovative cream is one of the most effective ways to revitalize the appearance of the skin on the face, décolleté, hands, and other body parts. Another significant product from LifeVantage is PhysIQ, a specialized diet and weight loss plan that is based on a complex formula for weight control and natural metabolism boosting. The plan includes specific nutritional supplements and supports training to promote weight loss. LifeVantage's business model is based on a network marketing concept. This means that the company does not rely on expensive marketing or advertising but instead builds a representative structure that sells the products directly through referrals and word-of-mouth. Representatives are encouraged to recruit new customers and earn commissions based on the products sold. LifeVantage's products are distributed worldwide and have established themselves as effective and safe methods for supporting physical well-being. The company emphasizes scientific research and works closely with experts to ensure that its products are always up to date with technology and research. Overall, LifeVantage is an innovative and reliable company that specializes in the development and manufacturing of high-quality biohacking products, helping customers achieve optimal health and well-being. The network marketing concept also makes it easy for beginners to earn a stable income by directly selling these innovative products to customers.

LifeVantage SWOT Analysis

Strengths

LifeVantage Corp has a strong product lineup consisting of scientifically-backed nutritional supplements and skincare products.

The company has built a solid reputation for using advanced biohacking techniques to improve overall health and wellness.

LifeVantage Corp has a robust network marketing distribution model, allowing for widespread product reach and efficient sales.

Weaknesses

LifeVantage Corp faces competition in the crowded health and wellness industry, which may make it challenging for the company to differentiate itself.

The dependence on network marketing may create a risk of overreliance on individual distributors, potentially affecting brand consistency and control.

The company's growth may be limited by regulatory restrictions in various markets, particularly related to health claims.

Opportunities

The increasing consumer trend towards preventive healthcare and wellness presents a significant opportunity for LifeVantage Corp to expand its market.

The expansion into international markets, particularly emerging economies with growing middle-class populations, could open up new revenue streams.

Collaboration with healthcare professionals and partnerships with research institutions can enhance the company's credibility and support the development of innovative products.

Threats

The health and wellness industry is subject to changing consumer preferences and trends, making it important for LifeVantage Corp to consistently adapt its product portfolio.

The potential emergence of new competitors with similar or even superior products may pose a threat to LifeVantage Corp's market position.

Stringent regulatory requirements, particularly related to product claims and marketing, can limit the company's ability to promote its products effectively.

LifeVantage Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

LifeVantage Employees
Details
Date
LifeVantage Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

LifeVantage Segments

LifeVantage Revenue by Segment (1/3)

  • Max

TrueScience® product line
AXIO® product line
PhysIQ™ product line
Petandim® product line
Details
Date
Protandim® product line
TrueScience® product line
Other
AXIO® product line
PhysIQ™ product line
Petandim® product line
Jan 1, 2025
0.00 USD
48.71 M USD
0.00 USD
15.31 M USD
5.10 M USD
2.12 M USD

LifeVantage Revenue by Segment (2/3)

  • Max

Protandim® product line
LifeVantage® product line
Other
Details
Date
Protandim®product line
Protandim®
Protandim® product line
LifeVantage® product line
Product and Service, Other
TrueScience® product line
Other
LifeVantage TrueScience® skin care regimen
Jan 1, 2025
0.00 USD
0.00 USD
95.33 M USD
56.23 M USD
0.00 USD
0.00 USD
5.73 M USD
0.00 USD

LifeVantage Revenue by Segment (3/3)

  • Max

Reportable Segment
Details
Date
Reportable Segment
Jan 1, 2025
228.53 M USD

LifeVantage Revenue by Region

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

United States
Americas
Asia / Pacific
Total foreign markets
Asia/Pacific & Europe
Japan
Details
Date
United States
Americas
Segment, Geographical, Groups of Countries, Group One
Asia / Pacific
Total foreign markets
Asia/Pacific & Europe
Segment, Geographical, Groups of Countries, Group Two
Japan
Jan 1, 2014
136.76 M USD
141.23 M USD
0.00 USD
72.74 M USD
0.00 USD
0.00 USD
0.00 USD
61.87 M USD
Jan 1, 2019
151.97 M USD
163.24 M USD
0.00 USD
0.00 USD
0.00 USD
62.72 M USD
0.00 USD
40.80 M USD
Jan 1, 2020
155.48 M USD
166.34 M USD
0.00 USD
0.00 USD
0.00 USD
66.58 M USD
0.00 USD
42.34 M USD
Jan 1, 2021
144.90 M USD
154.66 M USD
0.00 USD
0.00 USD
0.00 USD
65.53 M USD
0.00 USD
41.17 M USD
Jan 1, 2022
130.93 M USD
138.32 M USD
0.00 USD
0.00 USD
0.00 USD
68.04 M USD
0.00 USD
36.81 M USD
Jan 1, 2023
148.52 M USD
155.36 M USD
0.00 USD
0.00 USD
0.00 USD
58.04 M USD
0.00 USD
32.08 M USD
Jan 1, 2024
145.68 M USD
152.91 M USD
0.00 USD
0.00 USD
0.00 USD
47.26 M USD
0.00 USD
26.99 M USD
Jan 1, 2025
178.44 M USD
0.00 USD
0.00 USD
0.00 USD
50.09 M USD
0.00 USD
0.00 USD
25.39 M USD

LifeVantage Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

LifeVantage historical P/E ratio, EBIT multiple, and P/S ratio

LifeVantage annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

LifeVantage shares outstanding

The number of shares of LifeVantage was 12.75 M in 2025. This indicates how many shares LifeVantage is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
13.29 M Stocks
Jan 1, 2022
12.54 M Stocks
Jan 1, 2023
12.61 M Stocks
Jan 1, 2024
13.18 M Stocks
Jan 1, 2025
12.75 M Stocks
Jan 1, 2026 (e)
12.75 M Stocks
Jan 1, 2027 (e)
12.75 M Stocks
Jan 1, 2028 (e)
12.75 M Stocks

LifeVantage stock splits

In LifeVantage's history, there have been no stock splits.

LifeVantage Dividend History

5 years of dividend payments · 3 consecutive increases

YearAnnual DividendYoY ChangePayments
20260.10USDYTD
Mar 2, 20260.05USD 0.0%1/2
Jun 1, 20260.05USD 11.1%2/2
20250.18USD 12.9%
Mar 3, 20250.04USD 0.0%1/4
May 30, 20250.05USD 12.5%2/4
Sep 8, 20250.05USD 0.0%3/4
Dec 1, 20250.05USD 0.0%4/4
20240.16USD 14.8%
20230.14USD 50.0%
20220.09USD

LifeVantage dividend history and estimates

In 2025, LifeVantage paid a dividend amounting to 0.18 USD. Dividend means that LifeVantage distributes a portion of its profits to its owners.
  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2022 (e)
0.09 USD
0.03 USD
Jan 1, 2023
0.14 USD
0.00 USD
Jan 1, 2024
0.16 USD
0.00 USD
Jan 1, 2025
0.18 USD
0.00 USD
Jan 1, 2026
0.19 USD
0.00 USD
Jan 1, 2027 (e)
0.00 USD
0.21 USD
Jan 1, 2028 (e)
0.00 USD
0.24 USD

LifeVantage dividend payout ratio

In 2025, LifeVantage had a payout ratio of 22.75%. The payout ratio indicates the percentage of the company's profits that LifeVantage distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
53.11 %
Jan 1, 2022
36.18 %
Jan 1, 2023
67.03 %
Jan 1, 2024
69.54 %
Jan 1, 2025
22.75 %
Jan 1, 2026 (e)
32.27 %
Jan 1, 2027 (e)
46.17 %
Jan 1, 2028 (e)
58.60 %

Current LifeVantage forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
87.50 % (7)
Hold
12.50 % (1)
Sell
0.00 % (0)
12M Price Target
14.79
Last Price
6.58
Currency
USD
12M Return Potential
124.77 %
LTM Return
0 %

LifeVantage Analyst Rating Actions

DateFirmActionRating
5/7/2026
Lake Street
Lake Street
DowngradeBuyHold
2/18/2026
Freedom Broker
Freedom Broker
MaintainedBuy
11/14/2025
Freedom Broker
Freedom Broker
MaintainedBuy
2/12/2014
Imperial Capital
Imperial Capital
MaintainedIn Line

LifeVantage Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/25/20260.13USD-46.87 MUSD-2026 Q4
5/4/20260.16USD-48.72 MUSD-2026 Q3
2/4/20260.15USD-55.47 MUSD-2026 Q2
11/7/20240.16USD-50.62 MUSD-2025 Q1
5/2/20240.17USD-56.62 MUSD-2024 Q3
1/31/20240.04USD-55.74 MUSD-2024 Q2
8/21/20230.20USD-54.39 MUSD-2023 Q4
5/1/20230.15USD-52.87 MUSD-2023 Q3
1/30/20230.05USD-51.93 MUSD-2023 Q2
11/2/20220.15USD-51.03 MUSD-2023 Q1

EESG©

Eulerpool ESG Scorecard© for the LifeVantage stock

54/100
13
Environment
74
Social
75
Governance
E

Environment

20
Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees
Percentage of women in management
Percentage of Asian employees7.5
Share of Asian management
Percentage of Hispanic/Latino employees18.4
Hispano/Latino Management share
Percentage of Black employees1.1
Black Management Share
Percentage of white employees70.1
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

LifeVantage shareholder structure

% Name
15.89417%
The Capital Management Corporation
The Capital Management Corporation
6.88703%
Renaissance Technologies LLC
Renaissance Technologies LLC
5.76981%
Sudbury Capital Management, LLC
Sudbury Capital Management, LLC
5.09936%
Fife (Steven R)
Fife (Steven R)
4.34568%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
4.17079%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
...

LifeVantage Beneficial Ownership Filings (SEC 13D/G)

Free Float
83.0%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
8.20%
The Vanguard Group
The Vanguard Group
SEC ↗
7.85%
26-0385758
26-0385758
SEC ↗
7.85%
13-3127734
13-3127734
SEC ↗
5.82%
View Capital L.P.
View Capital L.P.
SEC ↗
5.80%
BlackRock, Inc.
BlackRock, Inc.
SEC ↗
5.70%
Bradley L. Radoff
Bradley L. Radoff
SEC ↗
5.38%
The Vanguard Group - 23-1945930
The Vanguard Group - 23-1945930
SEC ↗
3.78%
Vanguard Index Funds - Vanguard Total Stock Market Index Fund - 23-2671505
Vanguard Index Funds - Vanguard Total Stock Market Index Fund - 23-2671505
SEC ↗
1.90%
(1) BlackRock, Inc.
(1) BlackRock, Inc.
SEC ↗
1.00%
The Radoff Family Foundation
The Radoff Family Foundation
SEC ↗

LifeVantage Executives and Management Board

15 members · avg. age 57 · 33 % women

SF

Mr. Steven Fife (66)

President, Chief Executive Officer, Director · since 2017

2.82 M USD

Management

TT

Mr. Todd Thompson (58)

Chief Information and Innovation Officer

1.02 M USD
JB

Ms. Julie Boyster (40)

Chief Marketing Officer

1.00 M USD
CA

Mr. Carl Aure (52)

Chief Financial Officer

698,276.00 USD
AN

Ms. Alissa Neufeld (46)

General Counsel, Corporate Secretary

521,871.00 USD
MO

Ms. Michelle Oborn-Virchow (45)

Chief People Officer

KC

Ms. Kristen Cunningham (41)

Chief Sales Officer

Board of Directors

RG

Mr. Raymond Greer (62)

Independent Chairman of the Board

191,668.00 USD
DL

Mr. Darwin Lewis (66)

Independent Director

184,753.00 USD
RA

Mr. Rajendran Anbalagan (49)

Independent Director

183,585.00 USD
DJ

Mr. Dayton Judd (54)

Independent Director

179,337.00 USD
CL

Ms. Cynthia Latham (67)

Independent Director

177,664.00 USD
MB

Mr. Michael Beindorff (73)

Independent Director

173,918.00 USD

LifeVantage Supply Chain

Frequently asked questions about LifeVantage

LifeVantage Corp is a company operating in the health and wellness industry. Its business model focuses on the development, manufacturing, and distribution of scientifically advanced nutritional supplements. LifeVantage Corp primarily offers products that aim to improve overall health and well-being, with a particular emphasis on cellular health. By leveraging scientific research and cutting-edge technologies, LifeVantage Corp strives to provide innovative solutions to individuals seeking to enhance their quality of life. Through its network marketing approach, the company also empowers independent distributors to share these products and earn income while promoting a healthier lifestyle.

LifeVantage Corp is primarily active in the health and wellness industry.

The main competitors of LifeVantage Corp in the market are Amway, Herbalife, Nu Skin Enterprises, and Usana Health Sciences.

LifeVantage Corp is a renowned health and wellness company established in 2003. Headquartered in Sandy, Utah, LifeVantage is dedicated to developing science-backed nutrigenomics products, aiming to redefine wellness and promote healthy living. With a mission to help individuals achieve their health goals, LifeVantage is committed to providing innovative nutritional supplements and skincare solutions that support overall well-being. As a leader in the direct-selling industry, LifeVantage has a global presence in North America, Europe, and the Asia-Pacific region. With its cutting-edge product line and focus on personalized health, LifeVantage Corp has become a trusted name in the wellness industry.

LifeVantage Corp has achieved several significant milestones in its journey. Firstly, the company successfully launched Protandim®, its flagship product, in 2005. This revolutionary dietary supplement gained immense popularity for its unique antioxidant properties. In 2008, LifeVantage Corp received widespread recognition when it was listed on the NASDAQ Stock Exchange. The company continued to expand its product portfolio and in 2016, introduced Axio®, a range of energy drinks. LifeVantage Corp's commitment to innovation and scientific research led to the development of NRF2 Synergizer™, a breakthrough formula in 2019. These achievements demonstrate LifeVantage Corp's continuous growth and dedication to providing high-quality wellness products to its consumers worldwide.

LifeVantage Corp primarily operates in countries and regions across the globe. The company has a significant presence in the United States, where it is headquartered. Additionally, LifeVantage Corp has established a strong foothold in Canada, Mexico, Japan, Australia, Hong Kong, and the Netherlands. With a wide-ranging international network, LifeVantage Corp continues to expand its footprint and reach customers in various markets.

LifeVantage Corp represents values and a corporate philosophy that emphasizes science-based solutions for better health and wellness. The company is committed to providing innovative products backed by extensive research and clinical studies. LifeVantage Corp is dedicated to empowering people to live healthier and happier lives through its leading-edge nutrigenomics technology. The company focuses on developing and distributing products that target oxidative stress, promote healthy aging, and support overall well-being. LifeVantage Corp's commitment to quality, integrity, and innovation drives its mission to help individuals achieve their health and financial goals. By combining cutting-edge science and a passion for transformative results, LifeVantage Corp is revolutionizing the way people approach their health and wellness.

Analysts currently set an average price target of 14.79 USD for the LifeVantage stock (median: 14.79 USD), implying +124.8 % versus the latest price. The consensus is based on 8 analyst ratings.

8 analysts currently rate the LifeVantage stock: 7 recommend buying, 1 holding and 0 selling. For 2026, analysts expect LifeVantage to generate revenue of 184.20 M USD and earnings per share of 0.58 USD.

Converted at the current exchange rate, the LifeVantage share trades at 5.80 EUR (6.69 USD).

The LifeVantage share (LFVN) is listed on 2 stock exchanges, including: NASDAQ (LFVN), Frankfurt (L2T1.F).

The LifeVantage Corporation is a company that operates in the health and wellness market. It is considered a leading provider of nutritional supplements and skincare products. The company's business models are centered around direct selling and multi-level marketing (MLM), which means that independent distributors sell the products directly to end customers. The main products of LifeVantage are the nutritional supplements Protandim, Axio, and PhysIQ, as well as the skincare series TrueScience. All of these products are designed to improve the health and well-being of the user. Protandim is a nutritional supplement that has antioxidant and anti-inflammatory properties to support the immune system and cellular health. Axio is a drink-like nutritional supplement specifically designed to enhance mental clarity and energy. PhysIQ contains products that focus on healthy weight loss, metabolism, and digestive issues, while TrueScience skincare products provide antioxidant protection, anti-aging properties, and moisture to reduce damage from environmental factors or aging. According to the company, all products undergo comprehensive clinical studies to ensure effectiveness and safety, in order to provide customers with essential quality standards. The production of LifeVantage products takes place in excellent manufacturing facilities, and all ingredients are carefully reviewed. LifeVantage products are sold directly to independent distributors, who then sell these products to end customers. The multi-level marketing model of LifeVantage is aimed at supporting independent distributors. These distributors are able to build their own sales by selling products to customers and recruiting new distributors. Through this process, they can also earn commissions and increase their income by selling LifeVantage products and acquiring customers in their team. The LifeVantage Corporation also has a presence on social media platforms such as Facebook, Twitter, Instagram, and LinkedIn. Here, customers and prospects can be informed about current products and offers and establish connections with others in the LifeVantage community. They can also share their own experiences and make recommendations. Overall, the business model of LifeVantage is focused on direct sales and multi-level marketing. It provides independent distributors with the opportunity to build their own sales by selling products to customers and recruiting new distributors. Through this model, distributors can earn commissions and increase their income. LifeVantage products are tested for effectiveness and safety through clinical studies and are sold directly to distributors, who then resell them to end customers. The company's presence on social media and its focus on health and wellness-oriented products ensure that LifeVantage continues to be on a growth trajectory.

The expected revenue of LifeVantage is 184.20 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of LifeVantage is 7.45 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of LifeVantage is currently 11.45. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the LifeVantage stock.

The price-to-sales ratio (P/S) of LifeVantage is currently 0.46. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the LifeVantage stock.

The Eulerpool Quality Score for LifeVantage is 3/10.

The ISIN of LifeVantage is US53222K2050. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of LifeVantage is A1420J. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of LifeVantage is LFVN. The ticker symbol is used to trade LifeVantage shares on the stock exchange.

Over the past 12 months, LifeVantage paid a dividend of 0.18 USD . This corresponds to a dividend yield of about 2.62 %. For the coming 12 months, LifeVantage is expected to pay a dividend of 0.21 USD.

The current dividend yield of LifeVantage is 2.62 %.

LifeVantage pays a dividend, distributed in the months of , , , .

LifeVantage paid dividends every year for the past 4 years.

For the upcoming 12 months, dividends amounting to 0.21 USD are expected. This corresponds to a dividend yield of 3.15 %.

LifeVantage is assigned to the 'Non-cyclical consumption' sector.

To receive the latest dividend of LifeVantage from amounting to 0.05 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, LifeVantage distributed 0.15 USD as dividends.

The dividends of LifeVantage are distributed in USD.

All fundamentals and in-depth analysis of LifeVantage

Our stock analysis for LifeVantage stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of LifeVantage. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.